Goodwill and Other Intangible Assets

3 Months Ended

Mar. 31, 2016

Goodwill and Intangible Assets Disclosure [Abstract]

A summary of changes in the Company’s goodwill by reportable business segment is as follows (in thousands):



	December 31, 2015		Dispositions			Purchase Price Adjustments		Foreign Currency		March 31, 2016
Segment
North America	$	2,640,409	$	—		$	—	$	—	$	2,640,409
International	905,625		(684		)	163		18,698		923,802
	$	3,546,034	$	(684	)	$	163	$	18,698	$	3,564,211

As of March 31, 2016 and December 31, 2015, other intangible assets consisted of the following (in thousands):



		March 31, 2016							December 31, 2015
	Weighted- Avg Useful Lives (Years)	Gross Carrying Amounts		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amounts		Accumulated Amortization			Net Carrying Amount
Customer and vendor agreements	18.4	$	2,072,522	$	(350,105	)	$	1,722,417	$	2,071,928	$	(329,664	)	$	1,742,264
Trade names and trademarks—indefinite lived	N/A	321,505		—			321,505		318,048		—			318,048
Trade names and trademarks—other	14.5	2,865		(1,902		)	963		3,067		(2,058		)	1,009
Software	5.1	166,820		(61,046		)	105,774		170,085		(54,250		)	115,835
Non-compete agreements	4.9	13,549		(9,051		)	4,498		15,209		(8,770		)	6,439
Total other intangibles		$	2,577,261	$	(422,104	)	$	2,155,157	$	2,578,337	$	(394,742	)	$	2,183,595

Changes in foreign exchange rates resulted in a $1.5 million decrease to the carrying values of other intangible assets in the three months ended March 31, 2016. Amortization expense related to intangible assets for the three months ended March 31, 2016 and 2015 was $27.4 million and $39.8 million, respectively.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details